Pharmacogenetic Smoking Cessation Intervention in a Health Care Setting: A Pilot Feasibility Study

摘要

Introduction:There is increasing evidence that response to pharmacological treatment for nicotine dependence may be moderated by genetic polymorphisms. However, the feasibility, acceptability, and impact of genetically tailoring treatment in real-world clinical settings are unknown.